Volume 2 -                   RJMS 1995, 2 - : 200-206 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nilforushan M, Hashemi S, Shokoohi H. EFFICACY ASSESSMENT OF NEONATAL B.C.G VACCINATION. RJMS 1995; 2 :200-206
URL: http://rjms.iums.ac.ir/article-1-1951-en.html
Abstract:   (9944 Views)

BCG vaccine has been used since 1921 for primary prevention of tuberculosis in man. The immunogenic efficacy of this vaccine has been reported between 2 to 83/. in various studies.

In order to assess the efficacy of neonatal BCG vaccination in 200 infants who had received BCG vecctne at birth, BCG vaccine scars were measured and PPD test (5 unit strength) was performed at 3 months of age. The survey was carried out from September 1993 to June 1994 in Shahid Akbarabad/ and Firoozgar University Hospitals.

Positive BCG scars (defined, when ~ 3 mm in greater diameter) was present in 68/. of infants.

PPD test results were negative « 5mm) in 321. , suspecious (5-9 mm) in 51/. and positive(~ 10mm) in 1T1. of cases.

Proportion of positive PPD tests was higher in male (pa direct correlation between diameter of BCG scars and intensity of reaction to PPD tests.

The most common complication of BCG vaccination was lymphadenitis which was detected in 2/. of infants.

Full-Text [PDF 1251 kb]   (1912 Downloads)    
Type of Study: Research | Subject: Pediatric Infectious

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb